Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Teva
Queensland Health
Julphar
Fuji
Express Scripts
Baxter
Moodys
UBS

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021097

« Back to Dashboard

NDA 021097 describes VISICOL, which is a drug marketed by Salix Pharms and is included in one NDA. Additional details are available on the VISICOL profile page.

The generic ingredient in VISICOL is sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate. There are one thousand four hundred and twenty-six drug master file entries for this compound. Additional details are available on the sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate profile page.
Summary for 021097
Tradename:VISICOL
Applicant:Salix Pharms
Ingredient:sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.398GM;1.102GM
Approval Date:Sep 21, 2000TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Chinese Patent Office
Teva
Chubb
UBS
Fish and Richardson
Queensland Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.